Palvella Therapeutics (PVLA) Receivables (2013 - 2024)
Palvella Therapeutics' Receivables was $358,000 in Q4 2024, down 88.6% from $3.14 million a year earlier and down 59.3% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Receivables (2013 - 2024) Analysis & Trends
From Q4 2013 onward, Palvella Therapeutics has reported Receivables for 36 quarters.
- Receivables shows a five-year compound annual growth rate of -44.5% (FY2019 to FY2024).
- In earlier years, Receivables was $3.14 million in FY2023 (-70.3%), $10.58 million in FY2022 (+219.4%), $3.31 million in FY2021 (+94.2%) and $1.71 million in FY2020 (-74.9%).
- The Q4 2024 figure marks the lowest quarterly Receivables since Q1 2017.
- Compared with a year earlier, Receivables was higher in three of the last eight quarters, with growth averaging 66.6%.
- The best year-over-year quarter for Receivables over five years was Q2 2024 (growth of 376.3%); the worst was Q1 2022 (a decline of 89.6%).
- Per Business Quant data, PVLA's Receivables in the three quarters before Q4 2024 was $879,000 (Q3 2024), $4.53 million (Q2 2024) and $4.91 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Palvella Therapeutics | 2.01 Bn | 1.76 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 879,000.00 |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | 4.91 Mn |
| Dec 31, 2023 | 3.14 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 952,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 10.58 Mn |
| Sep 30, 2022 | 829,000.00 |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 3.31 Mn |
| Sep 30, 2021 | 6.65 Mn |
| Jun 30, 2021 | 2.80 Mn |
| Mar 31, 2021 | 15.81 Mn |
| Dec 31, 2020 | 1.71 Mn |
| Sep 30, 2020 | 2.94 Mn |
| Jun 30, 2020 | 10.71 Mn |
| Mar 31, 2020 | 7.27 Mn |
API Access
Palvella Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();